The Advancement Imperative: Why Delaware's Javice Ruling Forces a Reckoning on D&O Indemnification Strategy

The High Cost of “Bad Faith”

Delaware’s Court of Chancery has once again demonstrated that advancement rights are not merely contractual boilerplate but a formidable substantive entitlement that courts will enforce even against the objections of sophisticated counterparties. In a July 2, 2026 ruling that has sent ripples through deal counsel and D&O insurance circles, Magistrate Judge Christian Wright held that JPMorgan Chase & Co. must continue advancing legal fees to Charlie Javice—the founder of the student financial aid startup Frank, who was convicted of defrauding the bank—rejecting the argument that her fee requests were so unreasonable as to constitute bad faith.

The decision in JPMorgan Chase Bank, N.A. v. Javice underscores a critical asymmetry in Delaware corporate law: while corporations may ultimately seek recoupment of advanced funds following a final adjudication of misconduct, the threshold for cutting off advancement mid-stream is deliberately prohibitive. For practitioners, the ruling serves as a stark reminder that advancement provisions are not “pay-to-play” arrangements contingent on the corporation’s satisfaction with the defense strategy, but rather vested rights that survive even serious allegations of fraud.

The “Challenging Burden” Standard

Magistrate Judge Wright’s analysis turned on the stringent standard governing termination of advancement obligations under Delaware law. Under 8 Del. C. § 145, advancement is a mandatory obligation unless the corporation’s charter or bylaws provide otherwise, and courts have consistently held that doubts about the propriety of advancement are resolved in favor of the indemnitee. Here, JPMorgan argued that Javice’s requested fees—reportedly substantial given the parallel criminal and civil proceedings—were so excessive that they evidenced bad faith, thereby excusing the bank’s performance.

The court disagreed, finding that JPMorgan had not met the “challenging burden” required to establish that the fees were unreasonable or abusive. This burden requires more than sticker shock or disagreement with litigation strategy; it demands evidence that the indemnitee is engaging in clear abuse of the advancement right, such as seeking payment for patently unnecessary work or charging rates grossly disproportionate to market standards without justification. Wright’s ruling suggests that even in high-stakes fraud cases where the indemnitee faces criminal conviction, the advancement obligation remains robust unless the fee requests are objectively irrational.

“The advancement remedy is designed to provide immediate relief from the personal financial burden of defending oneself against claims arising from corporate service, not to subject the indemnitee’s defense decisions to hindsight review by the corporation.”

This reasoning aligns with the Delaware Supreme Court’s jurisprudence in Homestore, Inc. v. Tafeen, 888 A.2d 204 (Del. 2005), which emphasized that advancement proceedings are “summary in nature” and not the forum for litigating the merits of the underlying dispute or the reasonableness of every litigation decision. The Javice ruling extends this principle to the fee-reasonableness context, effectively requiring corporations to fund now and litigate reasonableness later—if at all.

Strategic Implications for M&A and D&O Coverage

For deal counsel, the immediate takeaway is that advancement provisions in acquisition agreements and corporate charters cannot be treated as mere formalities. JPMorgan’s predicament—continuing to fund the defense of an executive it believes defrauded it—illustrates the risk of broad advancement clauses that lack meaningful guardrails. While Delaware law permits corporations to condition advancement on an undertaking to repay if it is ultimately determined that the indemnitee is not entitled to indemnification, it does not permit corporations to act as judge and jury regarding the quality of the defense being mounted.

Practitioners should consider whether standard advancement provisions need revision to address the “Javice scenario”: high-cost criminal defenses arising from alleged pre-acquisition misconduct. While Delaware courts are unlikely to enforce provisions that allow corporations to cut off funding based merely on the corporation’s subjective belief that the indemnitee is guilty, parties might negotiate more precise language regarding fee caps, hourly rate limitations, or mandatory preliminary review of fee applications by a neutral third party. However, any such limitations must be drafted with surgical precision; Delaware courts strictly construe advancement rights against the corporation, and ambiguous limitations will likely be read to preserve the broadest possible advancement.

The ruling also has significant implications for D&O insurance carriers. Advancement obligations typically sit at the intersection of corporate indemnification and insurance coverage, with carriers often advancing defense costs on behalf of the corporation or reimbursing the corporation for advancements made. The Chancery Court’s refusal to second-guess Javice’s fee requests suggests that carriers may face similar difficulties challenging defense costs as unreasonable under “reasonableness” clauses in D&O policies, particularly when the underlying litigation is complex and multi-forum.

The Recoupment Illusion

Critics of the ruling may argue that JPMorgan can simply seek recoupment later if Javice is ultimately found not entitled to indemnification. While technically true under 8 Del. C. § 145(c), this remedy is often illusory in practice. Once advanced funds are spent on legal fees, they are rarely recoverable from individual defendants, particularly those who have been convicted and face restitution orders and fines. The Javice case thus highlights the “advancement trap”: corporations are compelled to fund defenses that may ultimately prove successful in avoiding liability, or unsuccessful, leaving the corporation with no practical recourse for the millions spent.

This dynamic creates a perverse incentive structure in settlement negotiations. An indemnitee facing both civil and criminal exposure may have little incentive to moderate defense spending, knowing the corporation must foot the bill, while the corporation may be forced to fund a scorched-earth defense strategy that increases the risk of adverse findings that could trigger indemnification exclusions for fraud or bad faith.

Conclusion: Drafting for the Worst Case

The Javice ruling arrives at a moment when Delaware is otherwise recalibrating corporate governance standards—witness the Supreme Court’s recent validation of SB 21 and the Moelis decision. Yet on advancement, the state’s courts remain steadfastly protective of indemnitees. For practitioners, the lesson is clear: treat advancement clauses as high-stakes risk allocation provisions, not boilerplate. In an era of increasing regulatory scrutiny and parallel criminal-civil proceedings, the cost of advancement can rival the underlying transaction value. The Javice decision ensures that when disputes arise, Delaware will err on the side of funding the defense, leaving corporations to bear the risk that they are financing their own adversary’s war chest.